This document outlines the plans for the 2014 Presidents Conference organized by the International Foodservice Manufacturers Association (IFMA). Joe Bybel and Perry Miele will chair and vice chair the conference, which aims to provide senior foodservice industry leaders with relevant strategies and opportunities to connect with distributors and operators. The conference committee's goals include increasing attendance, sponsorship revenue, and participation from distributors and operators. Tactics to achieve these goals include developing the agenda, inviting speakers, executing a marketing plan, and assessing results to help plan the 2015 conference.
Mark johnson business model transformationifmaworld
Business model innovations have reshaped entire industries and redistributed billions of dollars of value. In best-selling author Mark Johnson’s enlightening presentation at Presidents Conference 2012, he shares insights that will help foodservice professionals develop the confidence to think about innovating their own business.
Mark johnson business model transformationifmaworld
Business model innovations have reshaped entire industries and redistributed billions of dollars of value. In best-selling author Mark Johnson’s enlightening presentation at Presidents Conference 2012, he shares insights that will help foodservice professionals develop the confidence to think about innovating their own business.
Taking your board to the next level bylaws, strategic plans, committeesNAFCareerAcads
Learn about how committees, bylaws and strategic plans can help streamline and
energize the work of your advisory board. Participants will receive a copy of a draft
advisory board operations manual.
Inspiring Participation, Providing Value - Findings and recommendations of th...Jason Lundell
Formal presentation of study and findings by the Members in Business and Industry Task Force to the Fort Worth Chapter Board of Directors of the Texas Society of Certified Public Accountants. Presented on December 10, 2009.
Taking your board to the next level bylaws, strategic plans, committeesNAFCareerAcads
Learn about how committees, bylaws and strategic plans can help streamline and
energize the work of your advisory board. Participants will receive a copy of a draft
advisory board operations manual.
Inspiring Participation, Providing Value - Findings and recommendations of th...Jason Lundell
Formal presentation of study and findings by the Members in Business and Industry Task Force to the Fort Worth Chapter Board of Directors of the Texas Society of Certified Public Accountants. Presented on December 10, 2009.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
2. IFMA Vision
“Providing our Member
Community and industry
partners the opportunity to
enhance the consumer’s
enjoyment of the foodservice
choice”
3. IFMA Mission
“Enabling our Member Community
to focus on critical issues affecting
their businesses and the industry”
4. IFMA 2020 Strategic Imperatives
Enhance
Value
of Consumer
Foodservice Choice
Consumers
Operators
Members
Focus Supporting Initiatives
Create New Consumer-Driven View of Foodservice Landscape
-Foodservice Landscape
-Foodservice Insights Library
Champion Industry-Wide Effort to Improve Consumer Choice
Co-Create Value Create Actionable Insights & Best Practices
with Operators Through
Demand-Creation
and Supply-Chain
Improvement Efforts
Enable Members to Excel
Given the New Basis of Competition
-Consumer Planning Program
-Operator Collaboration Model
-Foodservice Category management
-Foodservice Navigator
-Performance Benchmarking
-GS-1
Drive Learnings through Connectivity Forums
-Presidents Conference
-COEX
-Marketing & Sales
Leaders Forum
-Gold & Silver Plate
- Fundamentals
-Operator Forums
-Strategic Issues Series
-Small/Mid Size Business
-Washington Insights
-Website
-Industry Adoption Plan
5. Center of Insights
Insights that drive
strategy & execution
Center of Best Practices
Proven foodservice
best practices
Center of Connectivity
Connect to share, learn
and execute
Consumer Planning Program
C - S. Marshall VC – P. Gere
FSnavigator
C - D. Davis VC - R. Kirkpatrick
FS New View of Industry
C - D. Allison VC - R. Hepponstall
Performance Benchmarking
C – B. Shanley VC - TBD
Small/Midsize Business
C - M. Cannon VC - B. McClellan
Category Management
C – R. Ferranti VC – TBD
Center of Innovation Excellence
C - TBD VC - TBD
Educational Foundation
C – K. Schartner VC - J. Flood
GS1
C - B. Shanley VC - L. Oberkfell
Operator Collaboration Model
C - K. Delahunt VC - D. Davis
SCORE
C - L. Kimura
COEX
C - M. Cannon VC - D. Rizley
Foodservice Fundamentals
C – J. Green
Gold & Silver Plate
C - F. Graves VC – R. Hepponstall
Marketing & Sales Leaders Forum
C - TBD VC – P. Gere
Operator Forums
C - K. Schartner VC – TBD
Presidents Conference
C – J. Bybel VC – P. Miele
Strategic Issues Series
C - J. Green
Centers of Excellence
2014 COMMITTEE LEADERSHIP
Washington Insights
C - B. McClellan VC – TBD
Membership
C – TBD
VC – TBD
BOARD
LEADERSHIP
Audit
C – B. Shanley
VC – K.
Delahunt
Compensation
C – L. Kimura
VC – R. Ferranti
Awards
C – R. Ferranti
VC – TBD
Strategic Plan
C – L. Kimura
Governance
C – L. Kimura
VC – R. Ferranti
6. Presidents Conference
Objective:
Create a conference that provides Senior Leaders/Management relevant and
actionable strategies in a connectivity forum with senior distributor and
operator personnel to build business.
Positioning Statement:
For members Presidents/Senior Leadership wanting critical
(target)
market insight and top-to-top interaction with senior foodservice
(need)
channel partners, the “by-invitation” Presidents Conference provides
them with relevant, actionable and strategic information in a unique
top-to-top, open learning environment.
(point of differentiation)
7. Goals:
Presidents Conference
• Attendance Revenue: $ +7%
• Sponsorship Revenue: $ +1%
• Distributor Attendance: +5%
• Operator Attendance: 100
• Broker Attendance: +5%
• Total Paid Attendance: +6%
Strategies:
• Establish committee to set direction and support execution
• Build off 2013 program and “Foodservice 2020 Strategic Imperatives.” Evidence
progress on industry-wide initiatives
• Build and execute integrated marketing plan
• Link to OCM/FCM, CPP, FSN, New View and all IFMA Connectivity forums
• Assess results. Provide recommendation for 2015 program
8. Presidents Conference
Committee Members:
Joe Bybel Ventura Foods Chair
Perry Miele Nestle Vice Chair
Jennifer Bestafka Keurig Green Mountain
Deanna Brady Hormel
Mike Cannon Surlean Foods
Peter Cokinos Grecian Delight
Kevin Delahunt Sargento
Marc Desmarais Idahoan
Bob Elliot Nestle Professional
John Flood Wayne Farms
Larry Gertsakis Nestle Professional
Lisa Kermizis-Abraham Bigelow Tea
Kenya Klabzuba Par-Way Tryson
Bill McCullough Ventura
Barbara Powell Azar Nut
Herb Ring Hershey
David Rizley SCA Tissue
Michael Rutt Dakota Growers Pasta
Kathleen Schartner Farmer Brothers
Jim Schywstell Pinnacle Foods Group
Malcolm Simmonds Simplot
David StoneburnerRuiz Foods
Mike Villano Basic American Foods
Bill Day (IFDA Co-chair) Sysco
John Lehmann IFMA Liaison
9. Tactics
Presidents Conference
Strategy: Establish committee to set direction and support execution
Who When Done
Select Chair and Vice Chair IFMA w/o 1/6 w/o 2/1
Identify prospective committee members IFMA w/o 1/27 w/o 2/10
Review prospective committee members and preliminary deck with Chair & Vice Chair
Vice Chair
IFMA w/o 2/10 w/o 3/17
Internal review for strategic alignment IFMA w/o 2/3 w/o 2/3
Chair invites prospective committee members (as they agree let them know when first
when first conference call is)
JL w/o 2/4 w/o 2/4
Finalize committee JL w/o 2/11 w/o 2/24
Coordinate first committee meeting and send out preliminary deck (preread) JL w/o 2/18 w/o 2/11
Hold first committee meetings to review and finalize deck, and set calls Committee w/o 2/25 w/o 3/27
10. Tactics Presidents Conference
Strategy: Build off 2013 program and “Foodservice 2020 imperatives.” Evidence progress on
industry-wide initiatives
Who When Done
Ideation session-Key Issues & Opportunities Committee w/o 2/25 w/o 3/28
Draft agenda
Committee
w/o 4/15 w/o 3/18
Identify speakers, panelists and moderators Committee w/o 5/5 w/o 9/8
Create agenda from base content Committee w/o 5/12 w/o 6/9
Develop flow document Committee w/o 7/14 w/o 8/4
Specify room setup, F&B and AV requirements Committee w/o 9/22
Finalize agenda IFMA w/o 9/22
Set and execute prep schedule for speakers, panelists and moderators IFMA w/o 10/1
Secure PPT’s, videos, etc. IFMA w/o 10/1
Finalize Scripts IFMA w/o 10/1
Conduct rehearsals IFMA 11-3/4
11. Tactics
Strategy: Build and execute integrated marketing plan
Who When Done
Develop Communication plan, including all electronic, printed , web and personal
communications outlined
IFMA w/o 2/15 w/o 6/1
Draft creative brief for overall conference w/agency IFMA w/o 4/1 w/o 6/23
Synchronize with content development IFMA Ongoing Ongoing
Save the date email-Target All IFMA w/o 4/15 w/o 6/23
Website update including call for nominations IFMA w/o 4/18 w/o 6/23
Define targets Committee w/o 6/16 w/o 6/16
Email w/conference highlights/ Registration Opens IFMA w/o 6/16 w/o 6/23
Monitor and report status of communications plan and registrations IFMA Ongoing Ongoing
Conference highlight Mailer IFMA w/o 9/22
Follow-up calls by committee to operators that received invitations Committee w/o 9/29
IFMA & Committee calls to members IFMA &
Committee
w/o 8/12 w/o 8/12
Presidents Conference
12. Tactics
Presidents Conference
Strategy: Build and execute integrated marketing plan-Sponsorships
Who When Done
Determine Sponsorship opportunities TD,JL w/o 5/5 w/o 6/2
Communicate opportunities for FROR for last year’s Sponsors TD, CL w/o 5/19 w/o 6/9
Sponsorship Sell Sheet sent out TD, FM w/o 5/26 w/o 6/23
Submit Final List to Marketing and Event Management TD w/o 8/22
Tactics
Strategy: Link to OCM/FCM, CPP, FSN, New View and all IFMA Connectivity forums
Have member of PC committee make mention of conference on other calls Who When Done
Have member of other committees make mention on PC calls Ongoing Ongoing
IFMA make ‘call outs’ of ‘significant’ events on calls Ongoing Ongoing
IFMA include connectivity materials with meeting agenda/reminder Ongoing Ongoing